ExLibris header image
SFX Logo
Title: Gene therapy begins
Source:

Science [0036-8075] Culliton, B J yr:1990


Collapse list of basic services Basic
Sorry, no full text available...
Please use the document delivery service (see below)  
Holding information
Holdings in library search engine ALBERT GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. Culliton, Barbara J. "One-Step Closer for Gene-Therapy." Science 248.4960 (1990): 1182-1182. Link to SFX for this item
2. "Death-inducing gene therapy promising in panceatic cancer preclinical tests." Cancer biology & therapy 6.8 (2007): 1164-1175. Link to SFX for this item
3. Booth, C. "Pegademase bovine (PEG-ADA) for the treatment of infants and children with severe combined immunodeficiency (SCID)." Biologics: Targets & Therapy 3 (2009): 349-358. Link to Full Text for this item Link to SFX for this item
4. Moran, N. "First gene therapy approved." Nature biotechnology 30.12 (2012): 1153-1153. Link to SFX for this item
5. Gennery, Andrew R. "Transplantation of hematopoietic stem cells and long-term survival for primary immunodeficiencies in Europe: Entering a new century, do we do better?" The journal of allergy and clinical immunology 126.3 (2010): 602-10. Link to SFX for this item
6. Deakin, Claire T. "Accepting risk in clinical research: is the gene therapy field becoming too risk-averse?" Molecular therapy 17.11 (2009): 1842-1848. Link to Full Text for this item Link to SFX for this item
7. Aiuti, A. "Gene therapy for immunodeficiency due to adenosine deaminase deficiency." New England Journal of Medicine, The 360.5 (2008): 447-58. Link to SFX for this item
8. Veronese, Francesco M M. "The Impact of PEGylation on Biological Therapies." BioDrugs 22.5 (2008): 315-29. Link to SFX for this item
Select All Clear All

Expand list of advanced services Advanced